CoChat

Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study

Open access
Bell, Lauren N., Wang, Jiangxia, Muralidharan, Sriya, Chalasani, Sadhana, Fullenkamp, Allison M., Wilson, Laura A., Sanyal, Arun J., Kowdley, Kris V., Neuschwander-Tetri, Brent A., Brunt, Elizabeth M., McCullough, Arthur J., Bass, Nathan M., Diehl, Anna Mae, Unalp-Arida, Aynur, Chalasani, Naga · 2012 · Hepatology
Cited by 104

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

The PIVENS (Pioglitazone versus Vitamin E versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis [NASH]) trial demonstrated that pioglitazone and vitamin E improved liver histology to varying degrees, but the mechanisms are unknown. We conducted a study to examine the changes in adipose tissue insulin resistance (Adipo-IR) during the PIVENS trial and its relationship to histological endpoints. Adipo-IR (fasting nonesterified fatty acids [NEFAs] × fasting insulin) was calculated at baseline and after 16 and 96 weeks of therapy. Compared to placebo, the baseline Adipo-IR was not different in either the vitamin E group ( P = 0.34) or the pioglitazone group ( P = 0.29). Baseline Adipo-IR was significantly associated with fibrosis score ( P = 0.02), but not with other histological features or nonalcoholic fatty liver disease (NAFLD) activity score (NAS). After 16 weeks, compared to placebo, the pioglitazone group had a significant reduction in Adipo-IR (−15.7 versus −1.91; P = 0.02), but this effect did not persist at 96 weeks (−3.25 versus −4.28; P = 0.31). Compared to placebo, Adipo-IR in the vitamin E group did not change significantly either after 16 weeks ( P = 0.70) or after 96 weeks ( P = 0.85). Change in Adipo-IR at week 16 was not associated with changes in any histological parameters at week 96, but improvement in Adipo-IR at week 96 was significantly associated with improvement in ballooning ( P = 0.03), fibrosis ( P = 0.004), and NAS ( P = 0.01). Conclusion : Vitamin E improved liver histology independent of changes in Adipo-IR, and pioglitazone treatment acutely improved Adipo-IR, but this was not sustained. Changes in Adipo-IR were associated with changes in liver histology, including fibrosis. (Hepatology 2012)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.25805

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 6

  1. McClain, 2004, Mechanisms of nonalcoholic steatohepatitis., Alcohol, 34, 6779, 10.1016/j.alcohol.2004.07.007 · DOI
  2. Chalasani, 2009, Pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis: PIVENS trial design., Contemp Clin Trials, 30, 8896, 10.1016/j.cct.2008.09.003 · DOI · Paper page
  3. Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease., HEPATOLOGY, 41, 13131321, 10.1002/hep.20701 · DOI · Paper page
  4. Lomonaco, 2012, Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with NAFLD., HEPATOLOGY, 55, 13891397, 10.1002/hep.25539 · DOI · Paper page
  5. Marchesini, 1990, Glucose disposal, betacell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment., Gastroenterology, 99, 17151722, 10.1016/0016-5085(90)90478-J · DOI
  6. Greco, 2002, Mechanisms of hyperinsulinemia in Childs disease grade B liver cirrhosis investigated in free liver conditions., Gut, 51, 870875, 10.1136/gut.51.6.870 · doi:10.1136/gut.51.6.870

Cited by

See all 104

Metadata

Authors
Bell, L. N., Wang, J., Muralidharan, S., Chalasani, S., Fullenkamp, A. M., Wilson, L. A., Sanyal, A. J., Kowdley, K. V., Neuschwander-Tetri, B. A., Brunt, E. M., McCullough, A. J., Bass, N. M., Diehl, A. M., Unalp-Arida, A., & Chalasani, N.
Venue
Hepatology
Published
2012-10
Volume
56
Issue
4
Pages
1311-1318
ISSN
0270-9139 (ISSN-L)
OpenAlex
W1967524653
Cited by
104
References
9
FWCI
6.03
Type
journal article
Language
en
Open access
bronze
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1065 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. https://app.cochat.ai/papers/10.1002/hep.25805
The paper
Bell, L. N., Wang, J., Muralidharan, S., Chalasani, S., Fullenkamp, A. M., Wilson, L. A., Sanyal, A. J., Kowdley, K. V., Neuschwander-Tetri, B. A., Brunt, E. M., McCullough, A. J., Bass, N. M., Diehl, A. M., Unalp-Arida, A., & Chalasani, N. (2012). Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. Hepatology. https://doi.org/10.1002/hep.25805

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.